US 8900638
Solid preparation comprising alogliptin and metformin hydrochloride
granted A61KA61K31/155A61K31/513
Quick answer
US patent 8900638 (Solid preparation comprising alogliptin and metformin hydrochloride) held by Takeda Pharmaceutical Company Limited expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/155, A61K31/513, A61K45/06, A61K9/2018